Transaminase increases in both cohorts had a conventional self-limited pattern with a peak elevation within the first week of drug administration and returned to baseline values by days 10–15 of each cycle with a clear trend towards reduction with subsequent cycles.
← all excerpts
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials.
1
—
—